PrPC is involved in the pathogenesis of neurodegenerative diseases, such as dementia with Lewy bodies and Pick’s disease, inducing aggregates with α-synuclein, amyloid β aggregates, and tau protein (Corbett et al., 2020). This evidence concerns the gene MAPT and neurodegenerative disease.